Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas

In Vivo

Volumn 14, Issue 1, 2000, Pages 237-250

  Ghossein, Ronald A ^a   Carusone, Leo ^a   Bhattacharya, Satyajit ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast carcinoma; Malignant melanoma; Minimal residuai disease; Molecular diagnostics; Polymerase chain reaction; Prostatic carcinoma; Reverse transcriptase

Indexed keywords

BREAST CARCINOMA; HUMAN; IN VIVO STUDY; METASTASIS; PROSTATE CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SOLID TUMOR; TUMOR CELL;

EID: 0034084968     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Ashworth TR: A case of cancer in which cells similar to those in the tumours were seen in the blood afterdeath. Australian Med J 14: 146, 1869.
2. Engell HC: Cancer cells in the circulating blood. Acta Chir Scand 1955; suppl. 201.
3. Christopherson W: Cancer cells in the peripheral blood: A second look. Acta Cytol 9: 169-174, 1965.
4. Mossl TJ and Sanders DG: Detection of neuroblastoma cells in blood. J Clin Oncol 8: 736-40, 1990.
5. Redding WH, Coombes RC, Monaghan P, Clink HM, Imrie SF, Dearnaley DP, Ormerad MG, Sloane JP, Gazet JC, Powles TJ and Munro Neville A: Detection of micrometastases in patients with primary breast cancer. Lancet 2: 1271-3, 1983.
6. Stahel RA, Mabry M, Skarkin AT, Speak J and Bernal SD: Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol 3: 455-6, 1985.
7. Diel IJ, Kaufman M, Goerner R, Costa SD, Kaul S and Bastert G: Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 10: 1534-1539, 1992.
8. Pantel K, Izbicki J, Passlick B, Angstwurm M, Haussinger K, Thetter O and Riethmuller G: Frequency and prognostic significance of isolated tumor cells in bone marrow of patients with non-small cell lung cancer without overt metastases. Lancet 347: 649-53, 1996.
9. Lindemann F, Schlimock G, Dirschedl P, Witte J and Riethmuller G: Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal patients. Lancet 340: 685-9, 1992.
10. Pelkey TJ, Frierson HF and Bruns DE: Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 42: 1369-1381, 1996.
11. Kirk SJ, Cooper GG, Hoper M, Watt PC, Roy AD and Odling-Smee W: The prognostic significance of marrow micrometastases in women with early breast cancer. Eur J Surg Oncol 16: 481-485, 1990.
12. Salvadori B, Squicciarni P, Rovini D, Orefice S, Andreola S, Rilke F, Barletta L, Menard S and Colnaghi MI: Use of monoclonal antibody Mbr1 to detect micrometastases in bone marrow specimens of breast cancer patients. Eur J Cancer 26: 865-867, 1990.
13. Singletary SE, Larry L, Tucker SL and Spitzer G: Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients. J Surg Oncol 47: 32-36, 1991.
14. Courtemanche DJ, Worth AJ, Coupland RW and MacFarlane JK: Detection of micrometastases from primary breast cancer. Can J Surg 34: 15-19, 1991.
15. Miettinen M: Keratin subsets in spindle cell sarcomas Keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins. Am J Pathol 138: 505-13, 1991.
16. Thomas P and Battifora H: Keratins versus epithelial membrane antigen in tumor diagnosis-an immunohistochemical comparison of five monoclonal antibodies. Hum Pathol 18: 728-34, 1987.
17. Campana D and Pui CH: Detection of minimal residual disease in acute leukemias: Methodological advances and clinical significance. Blood 85: 1416-34, 1995.
18. Cave H, Guidal P, Rohrlich P, Delfau MH, Broyart A, Lescoeur B, Rahimy C, Fenneteau O, Monplaisir N, d'Auriol L, Elion J, Vilmer E and Grandchamp B: Prospective monitoring and quantitation of residual blasts in childhood acute leukemias by polymerase chain reaction of delta and gamma T-cell receptor genes. Blood 83: 1892-902, 1994.
19. Miyajama Y, Kato K, Numata S, Kudo K and Horibe K: Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer 75: 2757-61, 1995.
20. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C and Neumaier M: Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 12: 725-9, 1994.
21. Lee MS, Chang KS, Cabanillas F, Freireich EJ, Trujillo JM and Stass SA: Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science 237: 175-8, 1987.
22. Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M and Nakao K: Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 75: 2214-9, 1995.
23. Eeles RA, Janssen JGW, editors: Polymerase chain reaction. The technique and its applications Austin TX: RGLandes Cie, 1993.
24. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON and McCormick FP Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 85: 5698-702, 1988.
25. Qiu SD, Young CY, Bilhartz DL, Prescott JL, Farrow GM, He WW and Tindall DJ: In situ hybridization of prostatic-specific antigen mRNA in human prostate. J Urol 144: 550-6, 1990.
26. Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A Zhang ZF and Rosai J: Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: Clinical implications. J Clin Oncol 13: 1195-200, 1995.
27. Kaplan JC, Kahn A and Chelly. J Illegitimate transcription: Its use in the study of inherited disease. Hum Mutat 1: 357-60, 1992.
28. Mattano LA, Moss TJ and Emerson SG: Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 52: 4701-5, 1992.
29. Smith B, Selby P, Southgate J, Pittman K, Bradley C and Blair GE: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227-9, 1991.
30. Schoenfeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnett HD and Coombes RC: Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54: 2986-90, 1994.
31. Olsson CA, de Vries GM, Buttyan R and Katz AE: Reverse transcriptase-polymerase chain reaction for prostate cancer. Urol Clin Noth Am 24: 367-378, 1997.
32. Ghossein RA Coit D, Brennan M, Zhang ZF, Wang Y, Bhattacharya S, Houghton A and Rosai J: Prognostic significance of peripheral blood and bone marrow tyrosinase mRNA in malignant melanoma Clin Cancer Res 4: 419-428, 1998.
33. Young CYF, Montgomery BT andrews PE, Qui SD, Bilhartz DL and Tindall DJ: Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinonla cell line LNCaP. Cancer Res 51: 3748-3752, 1991.
34. Fukuhara T, Hooper WC, Baylin SB, Benson J, Pruckler J, Olson AC, Evatt BLL and Vogler WR Use of the polymerase chain reaction to detect hypermethylation in the calcitonin gene-a new sensitive approach to monitor tumor cells in acute myelogenous leukemia. Leukemia Res 16: 1031-1040, 1992.
35. Cross NC, Feng L, Chase A, Bungey J, Hughes TP and Goldman JM: Competitive polymerase chain reaction to estimate the number of bcr-abl transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 82: 1929-1936, 1993.
36. Meijerink JP, Smetsers TF, Raemaekers JM, Bogman MJ, De Witte T and Mensink EJ: Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) by competitive polymerase chain reaction. Br J Haematol 84: 250-256, 1993.
37. Brisco MJ, Condon J, Hughes E, Neoh SH, Sykes PJ, Seshadri R, Toogood I, Waters K, Tauro G, Ekert H and Morley AA: Outcome prediction in childhood acute lymphoblastic leukemia by molecular quantification of residual disease at the end of induction. Lancet 343: 196-200, 1994.
38. Heid CA, Stevens J, Livak KJ, Mickey Williams P: Real time quantitative PCR. Genome Res 6: 986-994, 1996.
39. Johnson PWM, Burchill SA and Selby PJ The molecular detection of circulating tumor cells. Br J Cancer 72: 268-76, 1995.
40. Israeli R, Miller WH, Su SL, Samadi DS, Powell CT, Heston WD, Wise GJ and Fair WR: Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: Comparison of prostatic-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 54: 6306-10, 1994.
41. Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, O'Toole KM, McMahon D, Benson MC and Buttyan R: Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 43: 765-75, 1994.
42. Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gagnes L, Kaplan I, Bubley G, De Wolf W and Sklar J: Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 12: 2634-2639, 1995.
43. Sokoloff MH, Tso CL, Kaboo R., Nelson S, Ko J, Dorey F, Figlin RA, Pang S, de Kernion, J and Belldegrun A: Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J Urol 156: 1560-1566, 1996.
44. Corey E, Arfman EW, Oswin MM, Melchior SW, Tindall DJ, Young CY, Ellis WJ and Vessella RE: Detection of circulating prostatic cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (Hk2) and prostatic-specific antigen (PSA) messages. Urology 50: 184-188, 1997.
45. Wood DP and Banerjee M: Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease free survival. J Clin Oncol 15: 3451-3457, 1997.
46. Gao C-L Maheshwari S, Dean RC, Tatum L Mooneyhan R Connelly R R, McLeod DG, Srivastava S, Moul JW: Blinded evaluation of reverse transcriptase- polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer. Urology 53: 714-721, 1999.
47. Ennis RD, Katz AE, de Vries GM, Heitjan DF, O'Toole KM, Rubin M, Buttyan R, Benson MC, Schiff PB: Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma. Cancer 79: 2402-8, 1997.
48. Ellis WJ, Vessella RL, Corey E, Arfman EW, Oswin MM, Melchior S, Lange PH: The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and follow up of patients with prostate cancer. J Urol 159(4): 1134-8, 1998.
49. Mao H, Hoshi S, Takahashi T, Kaneda T, Wang J, Suzuki K, Orikasa S: Detection of PSA mRNA from the peripheral blood and pelvic lymph nodes in patients with prostatic cancer by means of reverse transcription-polymerase chain reaction (RT-PCR). Nippon Hinyokika Gakkai Zasshi 89: 596-603, 1998.
50. Saimoto A, Saito S, Murai M: Prostate-specific membrane antigen-derived primers in a nested reverse transcription polymerase chain reaction for detecting prostatic cancer cells. Jpn J Cancer Res 90: 233-9, 1999.
51. rd, Kaufman JS, Daniels JM, Stolzenbereg SJ, Teigland CM: Detection and clearance of prostate cells subsequent to ultrasound- guided needle biopsy as determined by multiplex nested reverse transcription polymerase chain reaction assay. Urology 52: 261-266, 1998.
52. Grassa YZ, Gupta MK, Levin HS, Zippe CD, Klein EA: Combined nested RT- PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage. Cancer Res 58: 1456-1459, 1998.
53. Gomella LG, Raj GV, Moreno JG: Reverse-transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. J. Urol 158: 326-337, 1997.
54. de la Taille A, Olsson CA, Katz AE: Molecular staging of prostate cancer: dream or reality? Oncology 13(2): 187-194, 1999.
55. Olsson CA de Vries GM, Raffo AJ, Benson MC, O'Toole K, Cao Y, Buttyan RE and Katz AE: Preoperative reverse transcriptase polymerase chain reaction for prostatic specific antigen predicts treatment failure following radical prostatectomy. J Urol 155: 1557-1562, 1996.
56. de la Taille A Olsson CA Buttyan R Benson MC Bagiella E Cao Y Burchardt M Chopin DK Katz AE: Blood based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy. Int J Cancer 20: 84: 360-4, 1999.
57. Ghossein R, Rosai J, Scher HI, Seiden M, Zhang ZF, Sun M, Chang G, Berlane K, Krithivas K and Kantoff PW: Prognostic significance of detection of prostate specific antigen transcripts in the peripheral blood of patients with metastatic androgen independent prostatic carcinoma. Urology 50: 100-105, 1997.
58. Deguchi T, Doi T, Ehara H, Ito S, Takahashi Y, Nishino Y, Fujihiro S, Kawamura T, Komeda H, Horie M, Kaji H, Shimokawa K, Tanaka T and Kawada Y: Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 53: 5350-4, 1993.
59. Meyers F, de Vere WRW, Larkin E, et al. Bone marrow molecular staging of prostatic carcinoma: does it help?. Proc Am Soc Clin Oncol 14: 230, 1995.
60. Edelstein RA, Zietman AL, de las Morenas A, Krane RJ, Babayan RK Dallow KC, Traish A and Moreland RB: Implication of prostatic micrometastases to the pelvic lymph nodes: an archival tissue study. Urology 47: 370-375, 1996.
61. Price DK, Woodard WL and Teigland CM: Simultaneous detection of prostate specific antigen-expressing and prostate-specific membrane antigen expressing cells by a multiplex reverse transcriptase polymcrase chain reaction assay. Urol Oncol 1: 226-233, 1995.
62. Sun Y, Lin J, Katz AE and Fisher PB: Human prostatic carcinoma PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples. Cancer Res 57: 18-23, 1997.
63. Wright GL Jr, Haley C, Beckett ML and Schellhammer PF: Expression of the prostate biomarker 7E11-C5 in primary and metastatic prostatic carcinoma. Proc Am Assoc Cancer Res 35: 233, 1994.
64. Axelrod HR, Gilman SC, D'aleo CJ, Petrylak D, Reuter V, Gulfo JV, Saad A, Cordon-Cardo C and Scher HI: Preclinical results and immunohistochemical studies with 90Y-CYT-356: a new prostatic cancer therapeutic agent. J Urol 147: 361A, 1992.
65. Wright GL Jr, Haley C, Beckett ML and Schellhammer PF: Expression of prostate-specific membrane antigen in normal benign and malignant prostatic tissue. Urol Oncol 1: 18-28, 1995.
66. Lorie S, Dumas F, Eschwege P, Blanchet P, Benoit G, Jardin A, Lacour B: Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clin Chem 41: 1698-704, 1995.
67. Shen R, Su Z, Olsson CA and Fisher PB: Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc Natl Acad Sci USA 92: 6778-6782, 1995.
68. Seiden M and Sklar JL: PCR and RT-PCR -based methods of tumor detection: potential applications and clinical implications. In: VT DeVita S Hellman and SA Rosenberg (eds) Important Advances in Oncology pp 191-204 Philadelphia: Lippincott, 1996.
69. Schlimock G and Riethmuller G: Detection characterization and tumorigenicity of disseminated tumor cells in human bone marrow. Semin Cancer Biol 1: 207, 1990.
70. Ghalie R: The Osborne/Rosen article reviewed. Oncology 8: 36-40, 1994.
71. Osborne MP, Asina S, Wong GY, Old LJ and Cote RJ: Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: Sensitivity in a model system. Cancer Res 49: 2510-3, 1989.
72. Cote RJ, Rosen PP, Lesser ML, Old LJ and Osborne MP: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9: 1749-1756, 1991.
73. Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE and Moscinski LC: Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14: 1868-1876, 1996.
74. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH and Roth MS: Sensitive detection of occult breast cancer by the Reverse-Transcriptase Polymerase chain reaction. J Clin Oncol 12: 475-82, 1994.
75. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, Ueo H and Akiyoshi T: Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 55: 3417-3420, 1995.
76. Brown DC, Purushotam AD, Birnie GD and George WD: Detection of intraoperative tumor cell dissemination in patients with breast cancer by use of the reverse transcription and polymerase chain reaction. Surgery 117, 90-101, 1995.
77. Noguchi S, Aihara T, Nakamori S, Motomura K, Inaji H, Imaoka S and Koyama H: The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 74: 1595-1600, 1994.
78. Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S and Koyama H: Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase polymerase chain reaction Comparison between MUC1 mRNA and keratin 19 mRNA amplification. Am J Pathol 148: 649-656, 1996.
79. Mori M, Mimori K, Ueo H, Tsuji K, Shirashi T, Barnard GF, Sugimachi K and Akiyoshi T: Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 16: 128-132, 1998.
80. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R and Hoon DS: Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in lymph nodes and blood of breast cancer patients. J Clin Oncol 16: 2632-40, 1998.
81. Eltahir EM, Mallinson DS, Birnie GD, Hagan C, George WD, Purushotham AD: Putative markers for the detection of breast carcinoma cells in blood. Br J Cancer 77(8): 1203-1207, 1998.
82. Min CJ, Tafra L, Verbanac KM: Identification of superior markers for polymerase chin reaction detection of breast cancer metastases in sentinel lymph nodes. Cancer Res 58: 4581-4584, 1998.
83. Bostick PJ, Hoon DSB and Cote RC: Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer. N Engl J Med 339: 1643, 1998 [letter].
84. Ko Y, Klinz M, Totzke G, Gouni-Berthold I, Sachinidis A, Vetter H: Limitations of reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. Clin Cancer Res 4: 2141-6, 1998.
85. Krisman M, Todt B, Schroder J, Gareis D, Muller KM, Seeber S and Schutte J: Low specificity of cytokeratin 19 reverse transcriptase polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 13: 2769-2775, 1995.
86. Lopez-Guerrero JA, Gilabert PB, Gonzalez EB, Sanz Alonso MA, Perez JP, Talens AS, Oraval EA, de la Rubia Comos J, Boix SB: Use of reverse- transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen cytokeratin 19 and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry. J Hematotherapy 8: 53-61, 1999.
87. Slade MJ, Smith BM, Sinnett HD, Cross NCP, Coombes RC: Quantitative Polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol 17: 870-879, 1999.
88. Battaglia M, Pedrazzolli P, Palermo B, Lanza A, Bertolini P, Gibelli N, Da Prada GA, Zambelli A, Perotti C, Robustelli della Cuna G: Epithelial tumor cell detection and the unsolved problems of tested RT-PCR: a new sensitive one step method without false positive results. Bone Marrow Transplant 22: 693-698, 1998.
89. Sager R, Sheng S, Pemberton P, Hendrix MJ: Maspin A tumor suppressing serpin. Adv Exp Med Biol 425: 77-88, 1997.
90. Dc Graaf H, Maelandsmo GM, Ruud P, Forus A, Oyjord T, Fodstadt O, Hovig E: Ectopic expression of target genes may represent an inherent limitation of RT PCR assays used for micrometastasis detection: Studies on the epithelial glycoprotein gene EGP-2 Int. J Cancer 72: 191-196, 1997.
91. Watson MA, Fleming TP: Mammaglobin a mammary-specific member of the uteroglobin gene family is overexpressed in human breast cancer. Cancer Res 56(4): 860-5, 1996.
92. Zach O, Kasparu H, Krieger O, Hehenwarter W, Girschikofsky M, Lutz D: Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J Clin Oncol 17: 2015-19, 1999.
93. Bostick PJ, Huynh KT, Sarantou T, Turner RR, Qi K, Giuliano AE, Hoon DSB: Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple- marker RT-PCR. Int J Cancer 79: 645-651, 1998.
94. Battayani Z, Grob JJ, Xerri L, Noe C. Zarour H, Houvaeneghel G, Delpero JR, Birmbaum D, Hassoun J and Bonerandi JJ: Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 131: 443-447, 1995.
95. Buzaid AC and Balch CM: Polymerase chain reaction for detection of melanoma in peripheral blood: Too early to assess clinical value. J Natl Cancer Inst 88: 569-570, 1996.
96. Hoon DSB, Wang Y, Dale PS, Conrad AJ, Schmid P, Garrison D, Kuo C, Foshag LJ, Nizze AJ and Morton DL: Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13: 2109-16, 1995.
97. Kunter U, Buer J, Probst M, Duensing S, Dallmann I, Grosse J, Kirchner H, Schluepen EM, Volkenandt M, Ganser A and Atzpodien J: Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.. J Natl Cancer Inst 88: 590-594, 1996.
98. Brossart P, Keiholz U, Willhauck M, Scheibenbogen C, Mohler T and Hunstein W: Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 101: 887-889, 1993.
99. Foss AJ, Guille MJ, Occleston NL, Hykin PG, Hungerford JL and Lightman S: The detection of melanoma cells in peripheral blood by reverse transcriptase polymerase chain reaction. Br J Cancer 72: 155-159, 1995.
100. Pittman K, Burchill S, Smith B, Southgate J, Joffe J, Gore M and Selby P: Reverse transcriptase -polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. Ann Oncol 7: 297-301, 1996.
101. Mellado B, Guttierrez L, Castel T, Colomer D, Fontanillas M, Castro J and Estape J: Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients. Clin Cancer Res 5: 1843-8, 1999.
102. Curry BJ, Myers K and Hersey P: Polymerase chain reaction detection of melanoma cells in the circulation: Relation to clinical stage surgical treatment and recurrence from melanoma. J Clin Oncol 16: 1760-1769, 1998.
103. Farthman B Eberle, J Krasagakis K Gstottner M Wang N Bisson S Orfanos CE: RT PCR for tyrosinase mRNA positive cells in peripheral blood: Evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J Invest Dermatol 110: 263-267, 1998.
104. de Vries TJ Fourkour A Punt CJ van de Locht LT van den Bosch S de Rooij MJ Mensink EJ Ruiter DJ van Muijen GN: Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using a real-time quantitative RT PCR. Br J Cancer 80: 883-91, 1999.
105. Schitteck B Bodingbauer Y Ellwanger U Blaheta HJ Garbe C: Amplification of Melan A messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma. Br J Dermatol 141: 30-36, 1999.
106. Coit D, Ghossein RA, Vlamis V, Satagopan J, Livingston P, Rosai J and Houghton A: Prognostic significance of detection of tyrosinase mRNA in the peripheral blood and/or bone marrow of melanoma patients rendered surgically free of disease Presented at the 1998 annual meeting of the American Society of Clinical Oncology Los Angeles CA [Abstract #1981].
107. Brossart P Schmier JW Kruger S Willhauck M Scheibenbogen C Mohler T Keilholz U: A polymerase chain reaction based semi-quantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 55: 4065-8, 1995.
108. Muhlbauer M Langenbach N Stolz W Hein R Landthaler M Buettner R Bosserhoff AK: Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription PCR. Clin Cancer Res 5: 1099-1105, 1999.
109. Wang X, Heller R, VanVoorhis N, Cruse CW, Glass F, Fenske N, Berman C, Leo-Messina J, Rappaport D, Wells K, De Conti R, Moscinski L, Stankard C, Puleo C and Reintgen D: Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 220: 768-74, 1994.
110. Biegliek SC, Ghossein RA, Bhattacharya S and Coit DG: Detection of tyrosinase mRNA by reverse transcriptase polymerase chain reaction (RT-PCR) in melanoma sentinel nodes. Ann Surg Oncol 6: 232-240, 1999.
111. Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass F, DeConti R, Wayne Cruse C, Berman C, Fenske NA, Lyman GH, Reintgen DS: Molecular staging of malignant melanoma. JAMA 280: 1410-1415, 1998.
112. Keiljolz U: New prognostic factors in melanoma: mRNA tumour markers. Eur J Cancer 34: S37-S41, 1998.
113. Weiss L: Metastatic inefficiency. Adv Cancer Res 54: 159-211, 1990.
114. Sugarbaker PH: Metastatic inefficiency: The scientific basis for resection of liver metastases from colorectal cancer. J Surg Oncol 3: 158-60, 1993 (Suppl)
115. Martin VM, Siewert C, Scharl A, Harms T, Heinze R, Ohl S, Radbruch A, Miltenyi S and Schmitz J: Immunomagnetic enrichment of disseminated epithelial tumor cells from periphbral blood by MACS. Exp Hematol 26: 252-264, 1998.
116. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW and Uhr JW: Detection and characterization of carcinoma cells in blood. Proc Natl Acad Sci USA 95: 4589-4594, 1998.
117. Ghossein RA, Osman I, Bhattacharya S, Ferrara J, Fazzari M, Cordon- Cardo C and Scher HI: Detection of prostatic specific membrane antigen mRNA using immunobead reverse transcriptase polymerase chain reaction Diagn Mol Pathol 8: 59-65, 1999.
118. Johnson PWM, Burchill SA and Selby PJ: The molecular detection of circulating tumor cells. Br J Cancer 72: 268-276, 1995.